Wenqing Jiang

1.6k citations
48 papers · 701 indexed · 1 hit paper · h-index 13

Wenqing Jiang

46 papers receiving 699 citations

Hit Papers

Total Neoadjuvant Therapy With FOLFIRINOX Followed by Ind...3622018202620202023100200300

Peers

Wenqing Jiang
Comparison fields: 5 of 89
  • Oncology 387
  • Cancer Research 185
  • Pulmonary and Respiratory Medicine 229
  • Hepatology 31
  • Surgery 172
Replace Seong Jin Cho with:
Seong Jin Cho South Korea
Cristina Mancini Italy
Karl-Walter Jauch Germany
Reiko Shimokawa Japan
Arndt Hartmann Germany
Ke Yu China
Thomas C. Koslowsky Germany
Yangyang Xu China
Yue He China
Takashi Okuyama Japan
Wenqing Jiang relative to Seong Jin Cho South Korea Seong Jin Cho's profile →
Citations per field
00.5×2.5×
Seong Jin Cho · 1×
Citations per year

Countries citing papers authored by Wenqing Jiang

Since Specialization
Citations

This map shows the geographic impact of Wenqing Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqing Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqing Jiang more than expected).

Fields of papers citing papers by Wenqing Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenqing Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqing Jiang. The network helps show where Wenqing Jiang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wenqing Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wenqing Jiang Line = papers co-authored together Wenqing Jiang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20251
4 20252
5 20251
6 20241
7 20240
8 202315
9 20235
10 20224
11 202221
12 20221
13 20223
14 20201
15 20203
16 201921
17 201838
18 201817
19 20189
20 201227

About Wenqing Jiang

Wenqing Jiang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 48 papers that have together received 701 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Child and Adolescent Psychosocial and Emotional Development (4 papers), Attention Deficit Hyperactivity Disorder (4 papers), Cancer Genomics and Diagnostics (3 papers), Autism Spectrum Disorder Research (3 papers), Cancer Research and Treatments (3 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Oncology (387 citations), Cancer Research (185 citations) and Pulmonary and Respiratory Medicine (229 citations). Wenqing Jiang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Thomas F. DeLaney, Jennifer Y. Wo, Theodore S. Hong, Jeffrey W. Clark, Beow Y. Yeap, Janet E. Murphy, Lawrence S. Blaszkowsky, Lipika Goyal, Andrew X. Zhu and Jill N. Allen. Their work appears in journals such as Journal of Clinical Oncology, Cell Metabolism and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026